Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1165667

Cognitive Impairment In Cancer Patients


Ana Petranovic, Duska Petranovic, Paula Podolski, Maja Ploh , Ingrid Lovasic4
Cognitive Impairment In Cancer Patients // Multinational Association in Supportive Care in Cancer (MASCC) Annnual Meeting 2020/2021 Abstract Book
online, 2021. str. 174-174 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 1165667 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Cognitive Impairment In Cancer Patients

Autori
Ana Petranovic, Duska Petranovic, Paula Podolski, Maja Ploh , Ingrid Lovasic4

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Multinational Association in Supportive Care in Cancer (MASCC) Annnual Meeting 2020/2021 Abstract Book / - , 2021, 174-174

Skup
Multinational Association in Supportive Care in Cancer (MASCC) Annnual Meeting

Mjesto i datum
Online, 24.06.2021. - 26.06.2021

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Cancer Patients, cognitive function, cognitive impairment, CRD

Sažetak
Introduction: Previous data in literature indicates a large number of cancer patients exhibiting signs of cognitive impairment at the time of diagnosis, during treatment or many years after successful treatment. We present the results of our research in measuring the cognitive function in patients as well as a review of other risk factors for cognitive impairment in these patients. Methods: Using a Complex Reactiometar Drenovac, we measured cognitive functions in 200 newly diagnosed, therapy naive oncological-hematological patients (grouped by type of the tumour). In our research we used the following tests: test of convergent thinking, spatial visualization, visual orientation, learning and memory, operative thinking, reaction on sound and test of reaction on light. Results: Anemia and age were proven to be the most significant factors associated with cognitive dysfunction (p <0.001) but other reasons as well as renal dysfunction, sleep deprivation, dehydration, certain laboratory parameters, and certain drugs (chemotherapy, corticosteroids, analgesic, sedative) could influence cognitive functions too . Conclusions: It is necessary to be aware of cognitive impairment in cancer patients. Early recognition and correction of some reversible factors (anemia, dehydration, choice of therapy etc.) could significantly improve patients cognition and by this also improve their QoL.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Psihologija



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka


Citiraj ovu publikaciju:

Ana Petranovic, Duska Petranovic, Paula Podolski, Maja Ploh , Ingrid Lovasic4
Cognitive Impairment In Cancer Patients // Multinational Association in Supportive Care in Cancer (MASCC) Annnual Meeting 2020/2021 Abstract Book
online, 2021. str. 174-174 (poster, međunarodna recenzija, sažetak, znanstveni)
Ana Petranovic, Duska Petranovic, Paula Podolski, Maja Ploh , Ingrid Lovasic4 (2021) Cognitive Impairment In Cancer Patients. U: Multinational Association in Supportive Care in Cancer (MASCC) Annnual Meeting 2020/2021 Abstract Book.
@article{article, year = {2021}, pages = {174-174}, keywords = {Cancer Patients, cognitive function, cognitive impairment, CRD}, title = {Cognitive Impairment In Cancer Patients}, keyword = {Cancer Patients, cognitive function, cognitive impairment, CRD}, publisherplace = {online} }
@article{article, year = {2021}, pages = {174-174}, keywords = {Cancer Patients, cognitive function, cognitive impairment, CRD}, title = {Cognitive Impairment In Cancer Patients}, keyword = {Cancer Patients, cognitive function, cognitive impairment, CRD}, publisherplace = {online} }




Contrast
Increase Font
Decrease Font
Dyslexic Font